Latest Market Capitalization News

Almonty Industries has been added to the Russell 1000 and 3000 indexes, marking a key milestone in its market capitalization growth and enhancing its visibility among institutional investors.

After 11 years at the helm, Vicinity Centres’ Chairman Trevor Gerber will step down at the 2026 AGM, with seasoned financial veteran Patrick Allaway set to take over, signalling continuity in the company’s premium retail strategy.

After 11 years on the board, including seven as Chairman, Trevor Gerber will retire at Vicinity Centres’ 2026 AGM, with Patrick Allaway appointed Chairman-elect to succeed him.

S&P Dow Jones Indices has announced its June 2026 quarterly rebalance of the S&P/ASX indices, with ALS Limited entering the ASX 50 and several notable changes across the ASX 100 and 200 indices effective June 22.

Almonty Industries has announced a $700 million convertible senior notes offering due 2031, aiming to refinance existing debt and fund corporate initiatives amid rising tungsten demand.

Almonty Industries is set to join the prestigious Russell 1000 and 3000 indexes in June 2026, marking a significant milestone that highlights its growth and operational progress amid rising tungsten demand.

VRX Silica’s updated 2026 Bankable Feasibility Study for Arrowsmith North confirms robust economics with an ungeared NPV8 of A$179.2 million and binding offtake contracts securing nearly 1 million tonnes annually.

Electro Optic Systems (ASX:EOS) has closed its three-year turnaround and is now poised for growth, backed by a landmark high-energy laser contract, a major European acquisition, and a $175 million capital raise.

Brightstar Resources has secured full funding for its Goldfields Project, targeting 75,000oz gold production annually from mid-2027, while advancing the Sandstone Project towards a potential Tier-1 development with production aimed for 2029.

Genesis Minerals has reported a 29% jump in gold resources to 18.9 million ounces and a 19% rise in reserves to 4.4 million ounces as of December 2025, underpinning its ASPIRE 500 growth strategy with new assets and exploration boosts.

ImpediMed has secured A$15.2 million through a two-tranche placement and share purchase plan, alongside A$5 million in cost reductions, aiming for operating cashflow breakeven by H2 FY28.

Blue Star Helium has completed Stage 1 of its Galactica development, tying six wells into the Pinon Canyon facility and starting spot-priced helium sales. The company raised A$10 million to fund further project expansion and working capital.